Cowen & Co. Initiates Coverage of GenMark, Nanosphere with Outperform Ratings | GenomeWeb

NEW YORK (GenomeWeb News) – Investment bank Cowen & Co. today initiated coverage of molecular diagnostics companies GenMark Diagnostics and Nanosphere with Outperform ratings.

In a report, analyst Shaun Rodriguez said that GenMark "presents a unique and compelling long-term value proposition in the diagnostics industry," and that the Carlsbad, Calif.-based firm is "a story with open-ended growth potential, a solid management team, superior technology, and targeting attractive markets."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.